Stay updated on TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T13:35:41.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:32:23.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Removed the 403 Forbidden text and the Home link, eliminating the error message and restoring the standard page layout.
    Difference
    0.5%
    Check dated 2026-09-28T16:37:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Page now displays a 403 Forbidden error with HTML indicating access is blocked, replacing the existing study record content and navigation. The result is that the trial details on this URL are not accessible, effectively removing core information from the page.
    Difference
    19%
    Check dated 2026-09-21T22:05:36.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, indicating a minor update to the page content since the previous revision (v3.6.5).
    Difference
    0.1%
    Check dated 2026-08-31T16:19:52.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Expanded indexing with a large set of study keywords and entity names (drugs, diseases, investigators, and institutions). Removed an error page block to restore access to content.
    Difference
    56%
    Check dated 2026-08-17T13:58:26.000Z thumbnail image

Stay in the know with updates to TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL and Anti-PD1 in Metastatic Melanoma Clinical Trial page.